1. Het cytochroom P450 enzymsysteem
- Subjects
Cytochrome P450 ,Genetic polymorfism ,phenobarbital ,rifampicin ,haloperidol ,methadone ,alprazolam ,thioridazine ,genetic polymorphism ,antibiotic agent ,psychosis ,chlorpromazine ,difantoine ,azithromycin ,roxithromycin ,sertraline ,drug hydroxylation ,phenytoin ,Substrate affinity ,cimetidine ,clarithromycin ,theophylline ,Liver enzymes ,unclassified drug ,Hydroxylation capacity ,carbamazepine ,depression ,liver enzyme ,sertindole ,cytochrome P450 ,review ,heart arrhythmia ,moclobemide ,saquinavir ,ciprofloxacin ,unindexed drug ,propranolol ,human ,quinidine polygalacturonate ,enzyme analysis ,triazolam ,Drug metabolism ,fluoxetine ,indinavir ,drug metabolism ,cyclosporin ,cyclosporin A ,Metabolism ,drug oxidation ,cytochrome P450 isoenzyme ,epilepsy ,quinidine - Abstract
In man a great interindividual variability exists in the oxidative capacity to metabolize drugs. A major factor contributing to this phenomenon is the genetically determined hydroxylation-capacity of the cytochrome P450 enzyme system. The cytochrome P450 system comprises of several isozymes. For several isozymes (CYP2D6, CYP2C) a genetically based hydroxylation capacity has been demonstrated. A frequency distribution of the clearance shows a bimodal distribution with poor and extensive metabolizers. Applying standard dosing schemes of the drugs that are predominantly metabolised by these isozymes, a considerable number of patients will be intoxicated because of poor metabolism. In general, cytochrome P450 capacity is limited and substrate-affinity is high. Henceforth cytochrome P450 isozymes are likely targets for pharmacokinetic interactions.
- Published
- 1998